Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature.

@article{Hird2008RapidII,
  title={Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature.},
  author={Amanda E Hird and Edward Kaihua Chow and Lisa Marie Ehrlich and Linda J Probyn and Emily Sinclair and Darwin Yip and Y. W. Ko},
  journal={Journal of palliative medicine},
  year={2008},
  volume={11 8},
  pages={
          1156-61
        }
}
Renal cell carcinoma (RCC) represents approximately 3% of all adult cancers and is more common in males. Systemic treatment for RCC has improved following the introduction of sunitinib. Bone metastases are present in up to 50% of RCC patients. We report a case of rapid improvement in metastatic bone lesions, recorded by nuclear bone scan, in a male patient receiving localized palliative radiotherapy in addition to systemic sunitinib and zoledronic acid. Concurrently, quality of life and… CONTINUE READING
BETA

Similar Papers

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2007

Renal cell carcinoma: Current status and future prospects

BJ Drucker
  • Cancer Treat Rev 2005;31:536–545
  • 2005